Spyre Therapeutics Inc. – Filings and Transcripts

NASDAQ: SYRE
Share price (6/2/26): $69.16
Market cap (6/2/26): $6.006 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Updated info for already-effective prospectus

Registration of securities for employees

Shelf registration

Ownership Filter

Milligan Sandra

Fairmount Healthcare Fund II L.P., Fairmount Funds Management LLC, Kiselak Tomas

Albers Jeffrey W.

Henderson Michael Thomas

News Filter

Other Events, Financial Statements or Exhibits

Change in Directors, Officers or Compensation, Shareholder Vote Results, Financial Statements or Exhibits

Reports First Quarter 2026 Financial Results and Provides Corporate Update

Material Definitive Agreement, Financial Statements or Exhibits

Earnings Release or Operating Update, Other Events

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Definitive proxy

Other Filter

Scanned paper annual report submission

Notice of effectiveness

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC